Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

EPA:ALTUV - Euronext Paris - Matif - FR0013345493 - Common Stock - Currency: EUR

1.76  -0.03 (-1.68%)

Fundamental Rating

4

ALTUV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 104 industry peers in the Machinery industry. ALTUV has a bad profitability rating. Also its financial health evaluation is rather negative. ALTUV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALTUV has reported negative net income.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in each of the past 5 years.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

ALTUV's Return On Assets of 0.05% is on the low side compared to the rest of the industry. ALTUV is outperformed by 75.00% of its industry peers.
ALTUV has a worse Return On Equity (0.10%) than 75.00% of its industry peers.
With a Return On Invested Capital value of 3.03%, ALTUV is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ALTUV is significantly below the industry average of 9.34%.
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROIC 3.03%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a Profit Margin value of 0.08%, ALTUV is not doing good in the industry: 74.04% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ALTUV has declined.
Looking at the Operating Margin, with a value of 5.39%, ALTUV is in line with its industry, outperforming 41.35% of the companies in the same industry.
ALTUV's Operating Margin has improved in the last couple of years.
ALTUV has a Gross Margin (37.34%) which is in line with its industry peers.
ALTUV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTUV is destroying value.
The number of shares outstanding for ALTUV has been reduced compared to 1 year ago.
ALTUV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
ALTUV's Altman-Z score of 1.46 is on the low side compared to the rest of the industry. ALTUV is outperformed by 64.42% of its industry peers.
The Debt to FCF ratio of ALTUV is 4.83, which is a neutral value as it means it would take ALTUV, 4.83 years of fcf income to pay off all of its debts.
ALTUV's Debt to FCF ratio of 4.83 is in line compared to the rest of the industry. ALTUV outperforms 59.62% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that ALTUV is somewhat dependend on debt financing.
The Debt to Equity ratio of ALTUV (0.57) is worse than 63.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Altman-Z 1.46
ROIC/WACC0.45
WACC6.76%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.64 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a Current ratio (1.64) which is comparable to the rest of the industry.
ALTUV has a Quick Ratio of 1.64. This is a bad value and indicates that ALTUV is not financially healthy enough and could expect problems in meeting its short term obligations.
ALTUV's Quick ratio of 0.84 is on the low side compared to the rest of the industry. ALTUV is outperformed by 64.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.84
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALTUV have decreased strongly by -66.19% in the last year.
ALTUV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.42% yearly.
The Revenue has decreased by -8.23% in the past year.
The Revenue has been growing by 14.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%

3.2 Future

The Earnings Per Share is expected to grow by 48.32% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALTUV will show a quite strong growth in Revenue. The Revenue will grow by 9.18% on average per year.
EPS Next Y99.99%
EPS Next 2Y48.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.89%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ALTUV is valuated reasonably with a Price/Forward Earnings ratio of 8.55.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit cheaper than the industry average as 79.81% of the companies are valued more expensively.
ALTUV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE N/A
Fwd PE 8.55
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALTUV.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALTUV indicates a rather cheap valuation: ALTUV is cheaper than 94.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.02
EV/EBITDA 8.26
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

ALTUV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALTUV's earnings are expected to grow with 48.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.32%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%.
ALTUV's Dividend Yield is a higher than the industry average which is at 2.45.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y48.32%
EPS Next 3YN/A
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

BIO-UV GROUP SAS

EPA:ALTUV (8/5/2025, 7:00:00 PM)

1.76

-0.03 (-1.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-22 2025-07-22
Earnings (Next)N/A N/A
Inst Owners6.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.90M
Analysts86.67
Price Target3.06 (73.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.55
P/S 0.63
P/FCF 5.02
P/OCF 3.61
P/B 0.76
P/tB N/A
EV/EBITDA 8.26
EPS(TTM)0
EYN/A
EPS(NY)0.21
Fwd EY11.69%
FCF(TTM)0.35
FCFY19.93%
OCF(TTM)0.49
OCFY27.71%
SpS2.8
BVpS2.31
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROCE 4.13%
ROIC 3.03%
ROICexc 3.28%
ROICexgc 14.19%
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
FCFM 12.54%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexcg growth 3Y38.43%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Debt/EBITDA 3.4
Cap/Depr 58.57%
Cap/Sales 4.9%
Interest Coverage 250
Cash Conversion 126.83%
Profit Quality 15804.5%
Current Ratio 1.64
Quick Ratio 0.84
Altman-Z 1.46
F-Score5
WACC6.76%
ROIC/WACC0.45
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
EPS Next Y99.99%
EPS Next 2Y48.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%
Revenue Next Year13.89%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.12%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year209.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.04%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y10.6%
OCF growth 3Y27.9%
OCF growth 5YN/A